Company intelligence / Profile preview

Robotic Biology Institute

Tokyo (Koto-ku, Aomi), Tokyo, Japan

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Robotic Biology Institute develops and markets humanoid robotics platforms (notably LabDroid/Maholo) that automate laboratory experiments for life sciences and drug discovery, with proven improvements in reproducibility and research productivity. Their LabDroid Maholo robot has been successfully implemented in both drug screening (e.g., osteosarcoma) and in large-scale validation studies across multiple laboratories, and is being positioned for use in advanced, automated cell therapy manufacturing ecosystems.[3][7][9][10][4][6]

Industry: Drug Discovery Services

Partnerships

Yaskawa Electric CorporationJapan Science and Technology Agency (JST)AIST (National Institute of Advanced Industrial Science and Technology)Astellas PharmaPacBioiLAC

Beyond the preview

Go deeper on Robotic Biology Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robotic Biology Institute.

Explore the full profile